about
Strategies for Diabetes Management: Using Newer Oral Combination Therapies Early in the DiseasePolymorphisms in the nephrin gene and diabetic nephropathy in type 1 diabetic patientsEuropean rational approach for the genetics of diabetic complications--EURAGEDIC: patient populations and strategyInfluence of Familial Renal Glycosuria Due to Mutations in the SLC5A2 Gene on Changes in Glucose Tolerance over TimeNew susceptibility loci associated with kidney disease in type 1 diabetes.The Genetic Landscape of Renal Complications in Type 1 Diabetes.Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes.Low birth weight does not increase the risk of nephropathy in Finnish type 1 diabetic patients.Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial.Functional annotations of diabetes nephropathy susceptibility loci through analysis of genome-wide renal gene expression in rat models of diabetes mellitus.Health-related quality of life in patients with type 1 diabetes--association with diabetic complications (the FinnDiane Study).Cerebellar glucose during fasting and acute hyperglycemia in nondiabetic men and in men with type 1 diabetes.Age at onset of type 1 diabetes in parents and recurrence risk in offspringEffects of long-term fenofibrate treatment on markers of renal function in type 2 diabetes: the FIELD Helsinki substudy.SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes.Arterial stiffness and vascular complications in patients with type 1 diabetes: the Finnish Diabetic Nephropathy (FinnDiane) Study.The cross-sectional associations between sense of coherence and diabetic microvascular complications, glycaemic control, and patients' conceptions of type 1 diabetesPatients with type 1 diabetes show signs of vascular dysfunction in response to multiple high-fat meals.Age at onset and the risk of proliferative retinopathy in type 1 diabetesOxygen-induced impairment in arterial function is corrected by slow breathing in patients with type 1 diabetes.Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy.Decline in the cumulative incidence of severe diabetic retinopathy in patients with type 1 diabetes.Survival of patients with type 1 diabetes receiving renal replacement therapy in 1980-2007.Novel susceptibility locus at 22q11 for diabetic nephropathy in type 1 diabetes.Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years.A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus.Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes.Pre-eclampsia and pregnancy-induced hypertension are associated with severe diabetic retinopathy in type 1 diabetes later in life.Mutations and variants of the epithelial sodium channel gene in Liddle's syndrome and primary hypertension.Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes.Pulse pressure predicts incident cardiovascular disease but not diabetic nephropathy in patients with type 1 diabetes (The FinnDiane Study).Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation.Bacterial infections in patients with type 1 diabetes: a 14-year follow-up studyTime trends in mortality in patients with type 1 diabetes: nationwide population based cohort studyAdvanced glycation end products are direct modulators of β-cell function.Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe).Proteases and protease inhibitors of urinary extracellular vesicles in diabetic nephropathy.Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes.
P50
Q28069065-77C2D955-C96E-45B9-9455-300F77280ECEQ28182471-DB42117D-31D8-44DE-83D0-599072BD536EQ28241180-7469B2E7-4946-4B17-A7E5-77248EE1089BQ28552106-4DA9292A-9AE6-4912-8DBC-42FF9640122FQ29417066-DAD53F2B-16C3-459C-B0F6-87EF278D7170Q30275890-4495FDF1-1209-452E-85F3-157EA6D8D572Q30948705-AD3AAD85-107A-4670-955C-28AC565C3252Q33243530-406B5B58-0A75-4EEF-8695-4561CFDDF4AAQ33459001-9DF39791-7C25-40E1-8BE7-5BD9E1D031CCQ33479791-589DDE1B-52A7-4DE2-ADDF-EF9B69237976Q33520906-6056990E-DAAA-452F-B0CB-934D984A2207Q33546432-2C64B2BB-EBB1-460A-BF64-D40CF1CDBAD9Q33556531-65BBD1F4-D0E5-4C9E-927D-F15A348B6A9AQ33602077-D3DE0B16-7980-45F2-8D86-F16F68385CAAQ33710202-156E9E31-E786-45FA-8823-112733493405Q33736980-520BC754-FC21-47AB-A8B7-7B4889D8B06EQ33756811-57A9CF88-1FA5-4FFB-871A-F3B62DC773EAQ33792579-001BB682-7B28-483F-8659-59BE26BD1432Q33873142-446DDCDB-7948-4FC1-87D5-BDA2AD0FD2E3Q33920798-AE4A5FBC-6B49-415C-AE29-79E77F0C2083Q33940015-5412DBBD-2025-40A9-A52B-BA0A06D85E4BQ34003238-EC9FB0A7-68CC-4B48-930F-60B477CE4CA4Q34015945-B46F9F70-87E4-4465-BAF2-9FD55F0D0FA9Q34016561-083249E9-77EA-4D0F-A288-F3CE7F2987AEQ34084609-2F620704-61B2-4E9D-A211-0B03CBF38FB3Q34284033-4988C8AA-8AAA-43CD-86FF-F295CDA3E6B0Q34370502-5C7035F1-6516-4623-AF31-F496E30C4577Q34407459-F120F2FA-1846-485F-AC6E-7F9B33C816F4Q34467062-2041C226-D576-4617-B5F3-D61B8D1B5323Q34695419-7D347DF8-AC97-4DDE-931C-F0CE5E74E9DEQ34718385-02BCFE7D-E52F-4A13-833A-791CD35E8201Q34718404-FB0EC918-14CA-489E-B181-645E59560E04Q34787780-FB0C759C-90C2-44EA-B2A5-A0CE38496756Q35123469-6EDFECA7-E029-44B8-89D9-42589A2DDDBBQ35156640-9E131BDE-2201-42E3-86F7-044A02724F80Q35204393-13200EFC-8F68-49FA-9F50-35712E8F101DQ35227180-21CC5EE0-4F9B-4C06-AD7D-C7B03E08B481Q35247700-F9557D5F-0DBC-48A2-9317-AE2801565985Q35248154-A08DD532-F8E5-4D2A-85CD-66C1FD663FA9Q35405420-4C66DE17-8EC4-47AB-B2AD-F30D35DE5F59
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Per-Henrik Groop
@ast
Per-Henrik Groop
@en
Per-Henrik Groop
@es
Per-Henrik Groop
@nl
type
label
Per-Henrik Groop
@ast
Per-Henrik Groop
@en
Per-Henrik Groop
@es
Per-Henrik Groop
@nl
prefLabel
Per-Henrik Groop
@ast
Per-Henrik Groop
@en
Per-Henrik Groop
@es
Per-Henrik Groop
@nl
P106
P21
P31
P496
0000-0003-4055-6954